Sequencing shorter cfDNA fragments improves the fetal DNA fraction in noninvasive prenatal testing

Abstract excerpt

BACKGROUND: Sequencing cell-free DNA in maternal plasma is an effective noninvasive prenatal testing technique that has been used in fetal aneuploidy screening worldwide. However, its clinical application is limited by the low fetal fraction (<4%) of cell-free DNA in many singleton pregnancies, which usually results in screen failures or no calls. In addition, dizygotic twin contributions of cell-free DNA into...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cancer Genomics and Diagnostics
• Share to Fetal and Pediatric Neurological Disorders
• Share to Prenatal Screening and Diagnostics